Cannabis Suisse Financials
| CSUI Stock | USD 0.01 0.01 62.88% |
Cannabis |
Understanding current and past Cannabis Suisse Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Cannabis Suisse's financial statements are interrelated, with each one affecting the others. For example, an increase in Cannabis Suisse's assets may result in an increase in income on the income statement.
Cannabis Suisse Stock Summary
Cannabis Suisse competes with MERCK Kommanditgesells. Cannabis Suisse Corp. engages in the cultivation, production, and distribution of over-the-counter products, recreational tobacco products, and medical CBD oils. Cannabis Suisse Corp. was incorporated in 2016 and is based in Bell Gardens, California. CANNABIS SUISSE is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 10 North Neuman |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.cannabissuissecorp.com |
| Phone | 904 595 5820 |
| Currency | USD - US Dollar |
Cannabis Suisse Key Financial Ratios
Cannabis Suisse's financial ratios allow both analysts and investors to convert raw data from Cannabis Suisse's financial statements into concise, actionable information that can be used to evaluate the performance of Cannabis Suisse over time and compare it to other companies across industries.Cannabis Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cannabis Suisse's current stock value. Our valuation model uses many indicators to compare Cannabis Suisse value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cannabis Suisse competition to find correlations between indicators driving Cannabis Suisse's intrinsic value. More Info.Cannabis Suisse Corp is rated below average in return on asset category among its peers. It is rated below average in operating margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Cannabis Suisse by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Cannabis Suisse's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Cannabis Suisse Corp Systematic Risk
Cannabis Suisse's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Cannabis Suisse volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Cannabis Suisse Corp correlated with the market. If Beta is less than 0 Cannabis Suisse generally moves in the opposite direction as compared to the market. If Cannabis Suisse Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cannabis Suisse Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cannabis Suisse is generally in the same direction as the market. If Beta > 1 Cannabis Suisse moves generally in the same direction as, but more than the movement of the benchmark.
Cannabis Suisse November 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Cannabis Suisse help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cannabis Suisse Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cannabis Suisse Corp based on widely used predictive technical indicators. In general, we focus on analyzing Cannabis Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cannabis Suisse's daily price indicators and compare them against related drivers.
| Downside Deviation | 44.39 | |||
| Information Ratio | 0.1248 | |||
| Maximum Drawdown | 473.73 | |||
| Value At Risk | (54.89) | |||
| Potential Upside | 124.0 |
Complementary Tools for Cannabis Pink Sheet analysis
When running Cannabis Suisse's price analysis, check to measure Cannabis Suisse's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannabis Suisse is operating at the current time. Most of Cannabis Suisse's value examination focuses on studying past and present price action to predict the probability of Cannabis Suisse's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannabis Suisse's price. Additionally, you may evaluate how the addition of Cannabis Suisse to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |